CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies
- Yun Liang
- , Hui Liu
- , Zheming Lu
- , Wen Lei
- , Chaoting Zhang
- , Ping Li
- , Aibin Liang
- , Ken H. Young
- , Wenbin Qian
Research output: Contribution to journal › Letter › peer-review
53
Link opens in a new tab
Scopus
citations